Clinical trial
A Clinical Study to Evaluate the Long-term Efficacy and Safety of Sodium Oligomannate Capsules (GV-971)
NCT05181475 is registered in ClinicalTrials.gov with Green Valley (Shanghai) Pharmaceuticals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study to Evaluate the Long-term Efficacy and Safety of Sodium Oligomannate Capsules (GV-971)
- Lead sponsor
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- December 7, 2021
- Completion date
- June 30, 2025
- Enrollment
- 800 (actual)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.